aod9604 essendon Southern Cross University researchers developing peptide test Adson Fcps 4 3/4 Serr.
Description
Key finding: AOD 9604 reduced body weight by 5.4 kg, reduced fasting glucose by 23 mg/dL, and improved HbA1c by 0.6%
This enzyme is involved in the conversion of the amino acid homocysteine into methionine which is, in turn, required for DNA methylation
The clinical program and Phase 2b failure Phase 1 and 2a trials were successful , the peptide was safe, without significant side effects, and showed a mild lipolytic signal
Water, black coffee, and plain tea are fine during this window
Side effects are rare and typically mild
Thigh - give injections in the outer middle third of the thigh
